Ritu Baral
Stock Analyst at TD Cowen
(3.40)
# 982
Out of 5,113 analysts
46
Total ratings
48.72%
Success rate
6.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Maintains: Buy | $202 → $306 | $278.75 | +9.78% | 1 | Jan 9, 2026 | |
| VTVT vTv Therapeutics | Initiates: Buy | $67 | $33.86 | +97.87% | 1 | Jan 5, 2026 | |
| INSM Insmed | Maintains: Buy | $269 → $241 | $159.72 | +50.89% | 7 | Dec 18, 2025 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $97 → $133 | $86.98 | +52.91% | 3 | Dec 16, 2025 | |
| MIST Milestone Pharmaceuticals | Upgrades: Buy | $8 | $1.94 | +312.37% | 1 | Dec 15, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $251 → $353 | $294.04 | +20.05% | 1 | Dec 8, 2025 | |
| VERA Vera Therapeutics | Maintains: Buy | $60 → $73 | $47.22 | +54.60% | 2 | Dec 5, 2025 | |
| RNA Avidity Biosciences | Downgrades: Hold | $78 → $74 | $72.63 | +1.89% | 2 | Oct 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $35 → $39 | $26.86 | +45.20% | 2 | Sep 11, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $390 → $554 | $499.17 | +10.98% | 2 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.45 | - | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.19 | - | 2 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $282 → $371 | $361.35 | +2.67% | 4 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.03 | - | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $175 | $22.80 | +667.54% | 1 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $82.69 | - | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $0.67 | - | 1 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $16.60 | - | 1 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.90 | - | 2 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $34.45 | - | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.29 | - | 1 | Jun 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.46 | - | 2 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $605.07 | - | 2 | Jan 12, 2018 |
Krystal Biotech
Jan 9, 2026
Maintains: Buy
Price Target: $202 → $306
Current: $278.75
Upside: +9.78%
vTv Therapeutics
Jan 5, 2026
Initiates: Buy
Price Target: $67
Current: $33.86
Upside: +97.87%
Insmed
Dec 18, 2025
Maintains: Buy
Price Target: $269 → $241
Current: $159.72
Upside: +50.89%
Palvella Therapeutics
Dec 16, 2025
Maintains: Buy
Price Target: $97 → $133
Current: $86.98
Upside: +52.91%
Milestone Pharmaceuticals
Dec 15, 2025
Upgrades: Buy
Price Target: $8
Current: $1.94
Upside: +312.37%
Praxis Precision Medicines
Dec 8, 2025
Maintains: Buy
Price Target: $251 → $353
Current: $294.04
Upside: +20.05%
Vera Therapeutics
Dec 5, 2025
Maintains: Buy
Price Target: $60 → $73
Current: $47.22
Upside: +54.60%
Avidity Biosciences
Oct 29, 2025
Downgrades: Hold
Price Target: $78 → $74
Current: $72.63
Upside: +1.89%
ACADIA Pharmaceuticals
Sep 11, 2025
Maintains: Buy
Price Target: $35 → $39
Current: $26.86
Upside: +45.20%
Madrigal Pharmaceuticals
Aug 26, 2025
Maintains: Buy
Price Target: $390 → $554
Current: $499.17
Upside: +10.98%
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.45
Upside: -
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.19
Upside: -
Oct 21, 2024
Maintains: Buy
Price Target: $282 → $371
Current: $361.35
Upside: +2.67%
Aug 8, 2023
Initiates: Outperform
Price Target: n/a
Current: $6.03
Upside: -
Mar 22, 2023
Maintains: Outperform
Price Target: $125 → $175
Current: $22.80
Upside: +667.54%
Nov 23, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $82.69
Upside: -
Aug 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.67
Upside: -
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $16.60
Upside: -
Jul 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.90
Upside: -
Mar 2, 2021
Initiates: Outperform
Price Target: n/a
Current: $34.45
Upside: -
Jun 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.29
Upside: -
Jul 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $0.46
Upside: -
Jan 12, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $605.07
Upside: -